🌍 The Raleigh facility spans 65,000 sq. ft. and meets pharma-grade standards. Lelystad offers a 96,000 sq. ft. Grade A, sustainable space.
🥶 Dublin’s facility is massive at 300,000 sq. ft., focusing on cold-chain logistics. These expansions enhance Uniphar’s ability to deliver critical therapies globally.
Introduction:
Uniphar has recently announced the expansion of its global operations through the establishment of three new facilities strategically located in North Carolina, the Netherlands, and Ireland. This expansion aims to enhance the company’s ability to deliver specialized services and effective logistical solutions to its pharmaceutical and medical technology partners, addressing the complexities of modern therapy launches in diverse markets.
- The North Carolina facility spans 65,000 square feet and is designed to meet Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) standards, featuring both ambient and cold-chain storage, as well as clean rooms for clinical trials.
- Uniphar’s flagship facility in Lelystad, Netherlands, covers over 96,000 square feet with Grade A standards, incorporating sustainable design features such as solar energy and advanced racking systems.
- The Dublin facility boasts over 300,000 square feet and specifically addresses the increasing demand for cold-chain logistics, offering substantial storage capacity while adhering to LEED Gold standards.
- These new facilities enable Uniphar to provide comprehensive support throughout the therapy lifecycle, from clinical trials to product launch and distribution, enhancing the company’s position in the pharmaceutical logistics sector.
- The expansions reflect Uniphar’s strategic long-term commitment to meeting the growing demand for innovative therapies and addressing market access challenges faced by pharmaceutical companies globally.
Conclusion:
The establishment of Uniphar’s new facilities marks a significant development in the company’s capacity to support pharmaceutical partners and facilitate the delivery of critical therapies to patients. The strategic locations and advanced features of these facilities underline Uniphar’s commitment to addressing the complexities of the pharmaceutical supply chain, thereby solidifying its role as a leader in the logistics and distribution of innovative health solutions on a global scale.
